TECON(SZ:002100) Zheng Quan Shi Bao Wang·2025-09-10 12:39Core Viewpoint - TianKang Biological has shown significant growth in pig sales and revenue, while emphasizing cost control measures to enhance competitiveness in a challenging market environment [1][2][4] Company Performance - In August 2025, TianKang Biological sold 263,800 pigs, representing a month-on-month increase of 18.03% and a year-on-year increase of 10.15%, with sales revenue reaching 380 million yuan, up 13.43% from the previous month [1] - From January to August 2025, the company sold a total of 2.0155 million pigs, an increase of 8.24% compared to the same period last year [1] Cost Control Measures - The company has successfully reduced pig farming costs to 12.6 yuan/kg in August 2025, with self-bred and self-raised pig costs dropping to 11.8 yuan/kg [1][2] - The cost of pig farming has decreased significantly from approximately 17 yuan/kg in September 2022 to 12.6 yuan/kg in August 2025, reflecting a reduction of over 30% in three years [2] Market Environment - The average pig-to-grain price ratio in China fell below 6:1, indicating a downward trend in pig prices, which has led to the importance of cost control becoming more pronounced [1][4] - The pig farming industry is experiencing new characteristics, including shorter cycles and increased short-term volatility, which necessitates strong cost control capabilities for survival and growth [4] Competitive Strategy - TianKang Biological is enhancing its competitiveness and risk resistance through refined breeding management, improved production efficiency, and cost control measures, including the use of hedging tools to manage market price fluctuations [2][4] - The company anticipates further cost reduction potential as the prices of purchased piglets decline, indicating room for continued improvement in cost management [4]